DRAPER, Utah, Sept. 12, 2017 -- HealthEquity, Inc. (NASDAQ:HQY) (“HealthEquity” or the “Company”), the largest HSA non-bank custodian, today announced it plans to participate at the following upcoming investor conferences in September 2017:
Chardan Leadership Conference Call
Date: September 19, 2017
Time: 12:00 Noon Eastern Time
Location: Conference call by invitation from Chardan
Presenter: Jon Kessler, President and CEO and Darcy Mott, EVP and CFO
Webcast: Replay only
Cantor Fitzgerald Global Healthcare Conference
Date: September 25, 2017
Time: 4:45 p.m. Eastern Time
Location: InterContinental New York Barclay Hotel
Presenter: Jon Kessler, President and CEO and Darcy Mott, EVP and CFO
Webcast: None
Bank of America Merrill Lynch Healthcare and HCIT One-on-One Conference
Date: September 26, 2017
Time: Scheduled one-on-one meetings
Location: Bank of America Conference Center, Boston, MA
Presenter: Jon Kessler, President and CEO, Darcy Mott, EVP and CFO
Webcast: None
About HealthEquity
Founded in 2002, HealthEquity is one of the nation's largest health savings custodians. The Company's innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs. HealthEquity services more than 2.9 million health savings accounts for 87 health plan partners and employees at more than 34,000 companies across the United States.
Forward-looking statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the Company’s industry, business strategy, plans, goals and expectations concerning our market position, product expansion, future operations, revenue, margins, business outlook, profitability, future efficiencies, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the control of the Company. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, the continued availability of tax-advantaged, consumer-directed benefits to employers and employees, the Company’s ability to acquire and retain new network partners and to cross-sell its products to existing network partners and members, the Company’s ability to successfully identify, acquire and integrate portfolio purchases or acquisition targets, the Company’s ability to raise awareness among employers and employees about the advantages of adopting and participating in consumer-directed benefits programs, and the Company’s ability to identify and execute on network partner opportunities. For a detailed discussion of these and other risk factors, please refer to the risks detailed in the Company’s filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. The Company undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this press release.
Investor Relations Contact:
Richard Putnam
801-727-1209
[email protected]


Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



